ESTRELLA IMMUNOPHARMA INC (ESLA) Stock Balance Sheet
USA - NASDAQ:ESLA - US2975841048 - Common Stock
2.55 USD
+0.09 (+3.66%)
2.55 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 40.00K | 40.00K | 480.00K | |||
| Cash Equivalents | 1.32M | 4.17M | 2.48M | 4.09M | N/A | |||
| Receivables | N/A | 0.00 | 273.10K | 0.00 | N/A | |||
| Other Current Assets | 163.90K | 288.80K | 0.00 | 833.30K | 140.00K | |||
| Total Current Assets | 1.48M | 4.45M | 2.75M | 4.92M | 620.00K | |||
| Non-Current Assets | ||||||||
| Investments And Advances | N/A | N/A | 9.67M | 9.67M | 45.19M | |||
| Other Non-Current Assets | 1.50M | 0.00 | 276.20K | 0.00 | N/A | |||
| Total Non-Current Assets | 1.50M | 0.00 | 276.20K | 0.00 | 45.18M | |||
| TOTAL ASSETS | 2.98M | 4.45M | 3.03M | 4.92M | 45.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 8.88M | 135.50K | 420.80K | 0.00 | 70.00K | |||
| Accounts Payable | 8.10K | 0.00 | 9.33M | 945.60K | 0.00 | |||
| Other Current Liabilities | 187.90K | 45.20K | 4.30K | 1.10K | N/A | |||
| Total Current Liabilities | 9.08M | 180.70K | 9.76M | 946.70K | 70.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | 30.00K | 30.00K | N/A | |||
| Other Non-Current Liabilities | N/A | 0.00 | 12.70K | 14.80K | 1.55M | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 12.70K | 14.80K | 1.55M | |||
| TOTAL LIABILITIES | 9.08M | 180.70K | 9.77M | 961.50K | 1.62M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -31.58M | -19.50M | -12.19M | -1.07M | -1.01M | |||
| Additional Paid In Capital | 26.08M | 24.12M | 445.60K | 34.30K | N/A | |||
| Common Shares | 3.80K | 3.70K | 5.00M | 5.00M | 45.19M | |||
| Treasury Stock | -598.40K | -354.40K | N/A | N/A | N/A | |||
| Shares Outstanding | 37.07M | 36.29M | 35.20M | 35.20M | 5.85M | |||
| Tangible Book Value per Share | -0.16 | 0.12 | -0.33 | -0.03 | 7.55 | |||
| Total Shareholders' Equity | -6.09M | 4.27M | -6.74M | 3.96M | 44.18M | |||
| TOTAL LIABILITIES AND EQUITY | 2.98M | 4.45M | 3.03M | 4.92M | 45.80M | |||
| Statistics | ||||||||
| Current Ratio | 0.16 | 24.65 | 0.28 | 5.20 | 8.86 | |||
| Return On Assets (ROA) | -405.17% | -164.15% | -367.01% | -34.24% | -0.55% | |||
| Return On Equity (ROE) | N/A | -171.09% | N/A | -42.56% | -0.57% | |||
All data in USD , ROIC based on taxRate of 0.21